Akb-6548-Ci-0015
ClinicalTrials.gov NCT02680574
Research payments
$1,840,609
Through program year 2021, $1,840,609 in research payments was reported against Akb-6548-Ci-0015, across 994 payments, paid by Akebia Therapeutics Inc.
- Paid by
- Akebia Therapeutics Inc
- ClinicalTrials.gov
- NCT02680574
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $1,840,609 | 994 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Eugenia Galindo Ramos Caguas, PR Named on 142 payments
- Rekha John Kinston, NC Named on 75 payments
- Jian Li Detroit, MI Named on 68 payments
- Aurelio Torres Consuegra Pembroke Pines, FL Named on 39 payments
- James Drakakis Mineola, NY Named on 37 payments
- Cecilio Hernandez Tampa, FL Named on 29 payments
- David Tietjen Huntsville, AL Named on 25 payments
- Arnold Silva Meridian, ID Named on 24 payments
- Darin Checketts Layton, UT Named on 21 payments
- Asghar Chaudhry Coral Springs, FL Named on 18 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.